MRNS

Marinus Pharmaceuticals, Inc
MRNS

Overview Fund Activity
Delisted

MRNS was delisted on the 10th of February, 2025.

Back to rankings

112 hedge funds and large institutions have $486M invested in Marinus Pharmaceuticals, Inc in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 36 reducing their positions, and 13 closing their positions.

Holders
112
Holders Change
+7
Holders Change %
+6.67%
% of All Funds
1.62%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
21
Increased
38
Reduced
36
Closed
13
Calls
$14.8M
Puts
$27M
Net Calls
-$12.2M
Net Calls Change
-$24.3M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$37.4M
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$7.68M
3
Citadel Advisors
3
Citadel Advisors
Florida
$11.2M
4
ABG
4
Ally Bridge Group
New York
$3.57M
5
WP
5
Woodline Partners
California
$10.7M

Top Sellers

1
EAM
1
Eventide Asset Management
Massachusetts
$21.2M
2
Morgan Stanley
2
Morgan Stanley
New York
$3.69M
3
OM
3
Opaleye Management
Massachusetts
$0
4
SI
4
Sofinnova Investments
California
$12.7M
5
Franklin Resources
5
Franklin Resources
California
$31.6M
Name Market Value Shares Shares
Change 		Shares
Change %
SCM
1
Suvretta Capital Management
New York
$46.2M 5,108,520 -237,599 -4%
BlackRock
2
BlackRock
New York
$42.7M 4,720,561 +121,283 +3%
ACA
3
Avoro Capital Advisors
New York
$37.4M 4,140,607 +990,607 +31%
Franklin Resources
4
Franklin Resources
California
$31.6M 3,493,253 -340,702 -9%
CAM
5
Cormorant Asset Management
Massachusetts
$29.4M 3,250,000 – –
Jennison Associates
6
Jennison Associates
New York
$26.8M 2,965,883 +6,722 +0.2%
Vanguard Group
7
Vanguard Group
Pennsylvania
$25.4M 2,805,920 +132,689 +5%
EAM
8
Eventide Asset Management
Massachusetts
$21.2M 2,346,526 -2,183,471 -48%
Adage Capital Partners
9
Adage Capital Partners
Massachusetts
$21.1M 2,331,250 -250,000 -10%
LPC
10
Lion Point Capital
New York
$19.2M 2,119,136 -15,201 -0.7%
BL
11
Bleichroeder LP
New York
$16.9M 1,872,463 – –
GC
12
GMT Capital
Georgia
$14.7M 1,629,364 -93,331 -5%
SI
13
Sofinnova Investments
California
$12.7M 1,401,053 -371,646 -21%
BCLSI
14
Bain Capital Life Sciences Investors
Massachusetts
$12.6M 1,393,380 -37,678 -3%
Citadel Advisors
15
Citadel Advisors
Florida
$11.2M 1,243,840 +647,444 +109%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$11M 1,214,766 +75,272 +7%
WP
17
Woodline Partners
California
$10.7M 1,186,781 +386,781 +48%
State Street
18
State Street
Massachusetts
$10.7M 1,181,744 +175,837 +17%
Balyasny Asset Management
19
Balyasny Asset Management
Illinois
$7.68M 849,447 +849,447 New
SCM
20
Superstring Capital Management
New York
$5.11M 565,550 +103,106 +22%
Aberdeen Group
21
Aberdeen Group
United Kingdom
$5M 552,572 – –
IC
22
Ikarian Capital
Texas
$4.86M 537,925 -208,144 -28%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$4.44M 491,617 -1,783 -0.4%
Northern Trust
24
Northern Trust
Illinois
$4.25M 469,598 +10,513 +2%
Morgan Stanley
25
Morgan Stanley
New York
$3.69M 408,063 -759,527 -65%
1
2 3 4 5